SpeedScreen: label-free liquid chromatography-mass spectrometry-based high-throughput screening for the discovery of

I Muckenschnabel1, R Falchetto, L M Mayr

  • 1Lead Discovery Center, Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland. ingo.muckenschnabel@pharma.novartis.com

Analytical Biochemistry
|December 24, 2003
PubMed

Related Concept Videos